FDA News Month in Review: January 2025

Name: Diabetes Dialogue: Understanding Semaglutide (Ozempic) in CKD and T2D
Uploaded: 2025-01-31T23:00:50.523Z
Duration: 12M42S
Description: Diabetes Dialogue: Understanding Semaglutide (Ozempic) in CKD and T2D

Author(s)Connor Iapoce

This FDA News Month in Review provides a round-up of regulatory decisions and submissions from January 2025.

Welcome back to our recap of this month's news and updates from the US Food and Drug Administration (FDA)!